Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $3.28 on Friday. The firm has a market cap of $17.55 million, a price-to-earnings ratio of -4.32 […]
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $3.28 on Friday. The firm has a market cap of $17.55 million, a price-to-earnings ratio of -4.32 […]
